| | | | | | Préparation | Taille des prés. | PEF | PP | QP | CQ | Composition | Titulaire de l'aut. | Cat. | | | | |
|---|
|
| avril 2025 - 74 Spécialités |
|
| | | | | | Beroseren | 40 | DDP | DDP | N.O. | | | Bayer (Schweiz) AG | D | FB | | G |  |
| | | | | | Beroseren | 120 | DDP | DDP | N.O. | | | Bayer (Schweiz) AG | D | FB | | G | |
| | | | | | Beroseren | 180 | DDP | DDP | N.O. | | | Bayer (Schweiz) AG | D | FB | | G | |
| | | IPro | | | Fluticason Leman 27.5 ug | 120 | DDP | DDP | N.O. | | | Leman SKL SA | B | FB | | G | |
| | | IPro | | V/S | mResvia Respiratorisches-
Synzytial-Virus (RSV)
Vakzin 0.10 mg/ml | | DDP | DDP | N.O. | | | Moderna Switzerland
GmbH | B | FB | | G | |
| | | IPro | | V/S | mResvia Respiratorisches-
Synzytial-Virus (RSV)
Vakzin 0.10 mg/ml | 10 | DDP | DDP | N.O. | | | Moderna Switzerland
GmbH | B | FB | | G | |
| | | | | CM | Hydromorphone Mundipharma 2 mg | 5 | DDP | DDP | N.O. | | Solution pour perfusion: Hydromorphoni Hydrochloridum 2 mg/ml | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | | | CM | Hydromorphone Mundipharma 2 mg | 10 | DDP | DDP | N.O. | | Solution pour perfusion: Hydromorphoni Hydrochloridum 2 mg/ml | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | | | CM | Hydromorphone Mundipharma 10 mg | 5 | DDP | DDP | N.O. | | Solution pour perfusion: Hydromorphoni Hydrochloridum 10 mg/ml | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | | | CM | Hydromorphone Mundipharma 10 mg | 10 | DDP | DDP | N.O. | | Solution pour perfusion: Hydromorphoni Hydrochloridum 10 mg/ml | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | | | CM | Hydromorphone Mundipharma 20 mg | 5 | DDP | DDP | N.O. | | Solution pour perfusion: Hydromorphoni Hydrochloridum 20 mg/ml | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | | | CM | Hydromorphone Mundipharma 20 mg | 10 | DDP | DDP | N.O. | | Solution pour perfusion: Hydromorphoni Hydrochloridum 20 mg/ml | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | | | CM | Hydromorphone Mundipharma 50 mg | 5 | DDP | DDP | N.O. | | Solution pour perfusion: Hydromorphoni Hydrochloridum 50 mg/ml | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | | | CM | Hydromorphone Mundipharma 50 mg | 10 | DDP | DDP | N.O. | | Solution pour perfusion: Hydromorphoni Hydrochloridum 50 mg/ml | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | IPro | | | Hylvastam 14 mg/ml | 12 x 250 ml | DDP | DDP | N.O. | | Solution pour perfusion: 2 Principes actifs | Leman SKL SA | B | FB | | G | |
| | | IPro | | | Hylvastam 14 mg/ml | 12 x 250 ml | DDP | DDP | N.O. | | Solution pour perfusion: 2 Principes actifs | Leman SKL SA | B | FB | | G | |
| | | IPro | | | Hylvastam 14 mg/ml | 12 x 500 ml | DDP | DDP | N.O. | | Solution pour perfusion: 2 Principes actifs | Leman SKL SA | B | FB | | G | |
| | | IPro | | | Hylvastam 14 mg/ml | 12 x 500 ml | DDP | DDP | N.O. | | Solution pour perfusion: 2 Principes actifs | Leman SKL SA | B | FB | | G | |
| | | | | | Pylclari 1000 MBq/ml | 1 ml | DDP | DDP | N.O. | | Solution injectable: Piflufolastatum(18-f) 1000 MBq/ml | b.e.imaging.ag | A | FB | | G | |
| | | | | | Pylclari 1500 MBq/ml | 1 ml | DDP | DDP | N.O. | | Solution injectable: Piflufolastatum(18-f) 1500 MBq/ml | b.e.imaging.ag | A | FB | | G | |
| | | | | | Steqeyma 130mg / 26mL | | DDP | DDP | N.O. | | Concentré pour perfusion: Ustekinumabum 130mg / 26ml | iQone Healthcare
Switzerland SA | B | FB | | G | |
| | | | | CM | Angomed | 50 | DDP | DDP | N.O. | | Comprimés filmés: 2 Principes actifs | Zeller Medical AG | D | FB | | G | |
| | | | | CM | Angomed | 100 | DDP | DDP | N.O. | | Comprimés filmés: 2 Principes actifs | Zeller Medical AG | D | FB | | G | |
| | | | | CM | Angomed | 200 | DDP | DDP | N.O. | | Comprimés filmés: 2 Principes actifs | Zeller Medical AG | D | FB | | G | |
| | | | | | Apixaban axapharm 2.5 mg | 20 | DDP | DDP | N.O. | | Comprimés filmés: Apixabanum 2.5 mg | axapharm ag | B | FB | | G | |
| | | | | | Apixaban axapharm 2.5 mg | 56 | DDP | DDP | N.O. | | Comprimés filmés: Apixabanum 2.5 mg | axapharm ag | B | FB | | G | |
| | | | | | Apixaban axapharm 2.5 mg | 100 | DDP | DDP | N.O. | | Comprimés filmés: Apixabanum 2.5 mg | axapharm ag | B | FB | | G | |
| | | | | | Apixaban axapharm 2.5 mg | 168 | DDP | DDP | N.O. | | Comprimés filmés: Apixabanum 2.5 mg | axapharm ag | B | FB | | G | |
| | | | | | Apixaban axapharm 5 mg | 56 | DDP | DDP | N.O. | | Comprimés filmés: Apixabanum 5 mg | axapharm ag | B | FB | | G | |
| | | | | | Apixaban axapharm 5 mg | 100 | DDP | DDP | N.O. | | Comprimés filmés: Apixabanum 5 mg | axapharm ag | B | FB | | G | |
| | | | | | Apixaban axapharm 5 mg | 168 | DDP | DDP | N.O. | | Comprimés filmés: Apixabanum 5 mg | axapharm ag | B | FB | | G | |
| | | | | | Dapagliflozin-Mepha 5 mg | 28 | DDP | DDP | N.O. | | Comprimés filmés: Dapagliflozinum 5 mg | Mepha Pharma AG | B | FB | | G | |
| | | | | | Dapagliflozin-Mepha 5 mg | 98 | DDP | DDP | N.O. | | Comprimés filmés: Dapagliflozinum 5 mg | Mepha Pharma AG | B | FB | | G | |
| | | | | | Dapagliflozin-Mepha 10 mg | 28 | DDP | DDP | N.O. | | Comprimés filmés: Dapagliflozinum 10 mg | Mepha Pharma AG | B | FB | | G | |
| | | | | | Dapagliflozin-Mepha 10 mg | 98 | DDP | DDP | N.O. | | Comprimés filmés: Dapagliflozinum 10 mg | Mepha Pharma AG | B | FB | | G | |
| | | | | | Imatinib Spirig HC 100 mg | 60 | DDP | DDP | N.O. | | Comprimés filmés: Imatinibum 100 mg | Spirig HealthCare AG | A | FB | | G | |
| | | | | | Imatinib Spirig HC 400 mg | 30 | DDP | DDP | N.O. | | Comprimés filmés: Imatinibum 400 mg | Spirig HealthCare AG | A | FB | | G | |
| | | | | | Nexpovio 20 mg | 8 | DDP | DDP | N.O. | | Comprimés filmés: Selinexorum 20 mg | Stemline Therapeutics
Switzerland GmbH | A | FB | | G | |
| | | | | | Nexpovio 20 mg | 12 | DDP | DDP | N.O. | | Comprimés filmés: Selinexorum 20 mg | Stemline Therapeutics
Switzerland GmbH | A | FB | | G | |
| | | | | | Nexpovio 20 mg | 16 | DDP | DDP | N.O. | | Comprimés filmés: Selinexorum 20 mg | Stemline Therapeutics
Switzerland GmbH | A | FB | | G | |
| | | | | | Nexpovio 20 mg | 20 | DDP | DDP | N.O. | | Comprimés filmés: Selinexorum 20 mg | Stemline Therapeutics
Switzerland GmbH | A | FB | | G | |
| | | | | | Nexpovio 20 mg | 32 | DDP | DDP | N.O. | | Comprimés filmés: Selinexorum 20 mg | Stemline Therapeutics
Switzerland GmbH | A | FB | | G | |
| | | | | | Rosuvastax-Drossapharm 5 mg | 30 | DDP | DDP | N.O. | | Comprimés filmés: Rosuvastatinum 5 mg | Drossapharm AG | B | FB | | G | |
| | | | | | Rosuvastax-Drossapharm 5 mg | 100 | DDP | DDP | N.O. | | Comprimés filmés: Rosuvastatinum 5 mg | Drossapharm AG | B | FB | | G | |
| | | | | | Rosuvastax-Drossapharm 10 mg | 30 | DDP | DDP | N.O. | | Comprimés filmés: Rosuvastatinum 10 mg | Drossapharm AG | B | FB | | G | |
| | | | | | Rosuvastax-Drossapharm 10 mg | 100 | DDP | DDP | N.O. | | Comprimés filmés: Rosuvastatinum 10 mg | Drossapharm AG | B | FB | | G | |
| | | | | | Rosuvastax-Drossapharm 20 mg | 30 | DDP | DDP | N.O. | | Comprimés filmés: Rosuvastatinum 20 mg | Drossapharm AG | B | FB | | G | |
| | | | | | Rosuvastax-Drossapharm 20 mg | 100 | DDP | DDP | N.O. | | Comprimés filmés: Rosuvastatinum 20 mg | Drossapharm AG | B | FB | | G | |
| | | | | | Nilotinib Spirig HC 50 mg | 120 | DDP | DDP | N.O. | | Capsules: Nilotinibum 50 mg | Spirig HealthCare AG | A | FB | | G | |
| | | | | | Nilotinib Spirig HC 150 mg | 112 | DDP | DDP | N.O. | | Capsules: Nilotinibum 150 mg | Spirig HealthCare AG | A | FB | | G | |
| | | | | | Nilotinib Spirig HC 200 mg | 28 | DDP | DDP | N.O. | | Capsules: Nilotinibum 200 mg | Spirig HealthCare AG | A | FB | | G | |
| | | | | | Nilotinib Spirig HC 200 mg | 112 | DDP | DDP | N.O. | | Capsules: Nilotinibum 200 mg | Spirig HealthCare AG | A | FB | | G | |
| | | | | | Pomalidomid Accord 1 mg | 21 | DDP | DDP | N.O. | | Capsules: Pomalidomidum 1 mg | Accord Healthcare AG | A | FB | | G | |
| | | | | | Pomalidomid Accord 2 mg | 21 | DDP | DDP | N.O. | | Capsules: Pomalidomidum 2 mg | Accord Healthcare AG | A | FB | | G | |
| | | | | | Pomalidomid Accord 3 mg | 21 | DDP | DDP | N.O. | | Capsules: Pomalidomidum 3 mg | Accord Healthcare AG | A | FB | | G | |
| | | | | | Pomalidomid Accord 4 mg | 21 | DDP | DDP | N.O. | | Capsules: Pomalidomidum 4 mg | Accord Healthcare AG | A | FB | | G | |
| | | | | CM | Coop Vitality Pantoprazol 20 mg | 14 | DDP | DDP | N.O. | | Comprimés résistants au suc gastrique: Pantoprazolum 20 mg | Coop Vitality Health
Care GmbH | D | FB | | G | |
| | | | | CM | Pantofelan 20 mg | 14 | DDP | DDP | N.O. | | Comprimés résistants au suc gastrique: Pantoprazolum 20 mg | G-Pharma AG | D | FB | | G | |
| | | | | | Viburcol | 50 | DDP | DDP | N.O. | | Comprimés: 6 Principes actifs | ebi-pharm ag | D | FB | | G | |
| | | | | | Protaminsulfat LEO Pharma
1400 Heparin-Antidot
I.E./ml | 5 x 5 ml | DDP | DDP | N.O. | | Injektionslösung und Infusionslösung: Protamini Sulfas 1400 UI/ml | LEO Pharmaceutical
Products Sarath Ltd. | B | FB | | G | |
| | | IPro | | | Teicoplanin-Evultis 200 mg | 5 | DDP | DDP | N.O. | | Polvere per soluzione iniettabile/per infusione o soluzione orale: Teicoplaninum 200 mg | Evultis SA | A | FB | | G | |
| | | IPro | | | Teicoplanin-Evultis 200 mg | 10 | DDP | DDP | N.O. | | Polvere per soluzione iniettabile/per infusione o soluzione orale: Teicoplaninum 200 mg | Evultis SA | A | FB | | G | |
| | | IPro | | | Teicoplanin-Evultis 400 mg | 5 | DDP | DDP | N.O. | | Polvere per soluzione iniettabile/per infusione o soluzione orale: Teicoplaninum 400 mg | Evultis SA | A | FB | | G | |
| | | IPro | | | Teicoplanin-Evultis 400 mg | 10 | DDP | DDP | N.O. | | Polvere per soluzione iniettabile/per infusione o soluzione orale: Teicoplaninum 400 mg | Evultis SA | A | FB | | G | |
| | | | | | Remicade 100 mg | | DDP | DDP | N.O. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Infliximabum 100 mg | Pharma Nova GmbH | A | FB | | G | |
| | | | | | Tepezza 500 mg | | DDP | DDP | N.O. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Teprotumumabum 500 mg | Amgen Switzerland AG | A | FB | | G | |
| | | | | | Carbetocin Aguettant 100
μg/mL | 5 | DDP | DDP | N.O. | | solution injectable en seringue préremplie: Carbetocinum 100 µg | Aguettant Suisse SA | A | FB | | G | |
| | | | | | Steqeyma 45mg / 0.5mL | | DDP | DDP | N.O. | | solution injectable en seringue préremplie: Ustekinumabum 45mg / 0.5ml | iQone Healthcare
Switzerland SA | B | FB | | G | |
| | | | | | Steqeyma 90mg / 1.0mL | | DDP | DDP | N.O. | | solution injectable en seringue préremplie: Ustekinumabum 90 mg/ml | iQone Healthcare
Switzerland SA | B | FB | | G | |
| | | | | | Metronidazole Lagap iv
500mg/100ml | 10 x 100 ml | DDP | DDP | N.O. | | soluzione per infusione: Metronidazolum 500mg / 100ml | Lagap SA | B | FB | | G | |
| | | | | | Metronidazole Lagap iv
500mg/100ml | 25 x 100 ml | DDP | DDP | N.O. | | soluzione per infusione: Metronidazolum 500mg / 100ml | Lagap SA | B | FB | | G | |
| | | | | | Metronidazole Lagap iv
500mg/100ml | 50 x 100 ml | DDP | DDP | N.O. | | soluzione per infusione: Metronidazolum 500mg / 100ml | Lagap SA | B | FB | | G | |
| | | | | V/S | Efluelda TIV 0.5 mL | | DDP | DDP | N.O. | | suspension injectable en seringue pré-remplie: 3 Principes actifs | Sanofi-Aventis
(Suisse) SA | B | FB | | G | |
| | | | | V/S | Efluelda TIV 0.5 mL | 10 | DDP | DDP | N.O. | | suspension injectable en seringue pré-remplie: 3 Principes actifs | Sanofi-Aventis
(Suisse) SA | B | FB | | G | |
